Angela Gaviria
University of Antioquia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Angela Gaviria.
International Journal of Gynecological Cancer | 2008
R. Hanisch; J. Gustat; M.E. Hagensee; Armando Baena; J.E. Salazar; M.V. Castro; Angela Gaviria; Gloria Inés Sánchez
This study evaluated Pap screening and human papillomavirus (HPV) knowledge in a population of Colombian women as a possible contributing factor of low cervical cancer screening success. This is a descriptive, cross-sectional analysis of 454 women who were approached in five different hospitals and clinics throughout Medellín, Colombia. Of them, 449 females agreed to participate and answered a standardized face-to-face questionnaire regarding Pap screening and HPV knowledge. Using logistic regression, predictors of both Pap and HPV knowledge were examined. Overall, 76.3% of the participants exhibited a high level of Pap screening knowledge, while only 7.8% showed high level of HPV knowledge. Of the 449 women, 71.5% reported that it had been 1 year or less since their last Pap test, while 7.8% reported never having had a Pap test or not having had a recent test. Factors influencing Pap screening knowledge included education level and insurance; factors influencing HPV knowledge included education level and age. The high level of Pap screening knowledge and use do not explain the high cervical cancer rates in Colombia. The results of this study suggest that educational efforts should be focused on increasing womens knowledge and awareness of HPV in anticipation of the availability of HPV vaccines and HPV tests for screening
Skin Research and Technology | 2008
Gloria Sanclemente; José-F Zapata; José-J García; Angela Gaviria; Luis-F Gómez; Marcela Barrera
Background: Sun exposure and skin phototype are the most relevant risk factors for skin cancer. Colombia has high levels of ultraviolet radiation during the whole year, therefore, both, high UVIs and outdoor workers daily activities, in our country are very important risk factors for the development of cutaneous cancer. To date no study has evaluated the usefulness of Fitzpatricks skin phototype classification in Colombians and its correlation with the minimal erythema dose (MED) and constitutional skin color. Such information is gaining importance in other nations due to the fact that several countrys population is becoming more ethnically diverse.
International Journal of Gynecological Cancer | 2012
Astrid Milena Bedoya; Angela Gaviria; Armando Baena; Mauricio Borrero; Diego F. Duarte; Alba Lucía Cómbita; Jorge Castaño; Hugo Grisales; Gloria Inés Sánchez
Objective The study’s objective was to estimate human papillomavirus (HPV) genotype–specific seroprevalence to determine population HPV exposure and inform vaccine policy. Methods This study is a cross-sectional prevalence survey of 878 women of Pueblorrico, a rural town of Colombia. A standardized questionnaire was used to obtain information on demographic characteristics, sexual and reproductive history, and smoking habits. Seropositivity to HPV-16, -18, -31, and -58 was determined by virus-like particles in an enzyme-linked immunosorbent assay. Results Overall seropositivity to any HPV genotype was 27.9%. The combined seroprevalence of women 15 to 19 and 20 to 24 years old was 35.4% (95% confidence interval [CI], 25.9–46.2) and 36.0% (95% CI, 27.7–45.3), respectively. Seroprevalence for HPV-16 was 17% (95% CI, 14.6–19.6); for HPV-18, 9.8% (95% CI, 8.0–11.9); for HPV-31, 11.4% (95% CI, 9.5–13.7); and for HPV 58, 12.5% (95% CI, 10.5–14.9). Higher HPV seropositivity was associated with the lifetime number of occasional sexual partners (odds ratio, 3.05; 95% CI, 1.26–7.37) and having more than 2 regular sexual partners (odds ratio, 3.00; 95% CI, 1.21–7.45) in women younger than 44 and older than 45 years old, respectively. Use of oral contraceptives and tobacco/cigarettes was significantly associated with reduced HPV seropositivity in women older than 45 but not in women younger than 44 years old. Conclusions Human papillomavirus seropositivity is associated with measures of sexual behavior, particularly a greater lifetime number of sexual partners. Hormonal and tobacco/cigarette use may be factors influencing the HPV seropositivity in women older than 45 years old.
Transactions of The Royal Society of Tropical Medicine and Hygiene | 2011
Clara Sierra; Astrid Milena Bedoya; Sara C. París; Armando Baena; Angela Gaviria; Carlos Rojas; María Patricia Arbeláez; Gloria Inés Sánchez
There is lack of age-specific seroprevalence surveys and identification of factors associated with herpes simplex virus type-2 seropositivity (HSV-2) in rural populations in Colombia. A random sample of 869 women was interviewed about socio-demographic aspects, sexual and reproductive history. Antibodies to HSV-2 were determined by a specific type immunoenzymatic technique (ELISA). Participants had a mean age of 38±16.1 years, 67% were married, 60% monogamous and 47% reported use of condoms. HSV-2 seroprevalence was 19.1% (95% CI: 16.6-21.9) and it was strongly associated with increasing age (Ptrend<0.001). In the logistic regression analysis, women who reported between two or three lifetime sexual partners (OR=2.4; 95% CI: 1.5-3.7), >31 years of sexual activity with regular or occasional sexual partners (OR=4.3; 95% CI: 1.2-15.7) and not using condoms with regular sexual partners (OR=2.1; 95% CI: 1.4-3.3) were more likely to be HSV-2 seropositive. The overall seroprevalence rate of women of Pueblorrico, Colombia, is lower than that reported in other Latin American countries especially in women>45 years. The difference may be explained by higher prevalence of condom use in this population or lower exposure to herpes infection in male as well as females in the past.
Journal of Clinical Virology | 2006
Viviana Cuberos; Juan Pérez; César Julián López; Felipe Castro; Leonor Victoria González; Luis Alfonso Correa; Gloria Sanclemente; Angela Gaviria; Martin Müller; Gloria Inés Sánchez
Journal of Clinical Virology | 2007
Silvia Herrera; Luis Alfonso Correa; Juan Carlos Wolff; Angela Gaviria; Stephen K. Tyring; Gloria Sanclemente
Biomedica | 2008
Hugo Grisales; Ángela Patricia Vanegas; Angela Gaviria; Jorge Castaño; Martín Alonso Mora; Mauricio Borrero; Carlos Rojas; María Patricia Arbeláez; Gloria Inés Sánchez
Revista Facultad Nacional de Salud Pública | 2014
Edwin Guevara; Armando Baena; Maribel Almonte; Jorge E. Salazar; Angela Gaviria; Gloria Inés Sánchez
Biomedica | 2008
Hugo Grisales; Ángela Patricia Vanegas; Angela Gaviria; Jorge Castaño; Martín Alonso Mora; Mauricio Borrero; Carlos Rojas; María Patricia Arbeláez; Gloria Inés Sánchez
Archive | 2013
Edwin Guevara; Armando Baena; Maribel Almonte; Jorge E. Salazar; Angela Gaviria; Gloria Inés Sánchez